2368 related articles for article (PubMed ID: 23530514)
1. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
2. Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice.
Kouznetsova E; Klingner M; Sorger D; Sabri O; Grossmann U; Steinbach J; Scheunemann M; Schliebs R
Int J Dev Neurosci; 2006; 24(2-3):187-93. PubMed ID: 16423498
[TBL] [Abstract][Full Text] [Related]
3. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
5. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.
Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R
Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380
[TBL] [Abstract][Full Text] [Related]
7. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
[TBL] [Abstract][Full Text] [Related]
8. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
Bigl M; Apelt J; Eschrich K; Schliebs R
J Neural Transm (Vienna); 2003 Jan; 110(1):77-94. PubMed ID: 12541014
[TBL] [Abstract][Full Text] [Related]
9. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations.
Foidl BM; Do-Dinh P; Hutter-Schmid B; Bliem HR; Humpel C
Neurobiol Learn Mem; 2016 Dec; 136():86-96. PubMed ID: 27670619
[TBL] [Abstract][Full Text] [Related]
11. Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology.
Klingner M; Apelt J; Kumar A; Sorger D; Sabri O; Steinbach J; Scheunemann M; Schliebs R
Int J Dev Neurosci; 2003 Nov; 21(7):357-69. PubMed ID: 14599482
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
[TBL] [Abstract][Full Text] [Related]
13. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
[TBL] [Abstract][Full Text] [Related]
15. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein.
Liskowsky W; Schliebs R
Int J Dev Neurosci; 2006; 24(2-3):149-56. PubMed ID: 16423497
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
Han BH; Zhou ML; Abousaleh F; Brendza RP; Dietrich HH; Koenigsknecht-Talboo J; Cirrito JR; Milner E; Holtzman DM; Zipfel GJ
J Neurosci; 2008 Dec; 28(50):13542-50. PubMed ID: 19074028
[TBL] [Abstract][Full Text] [Related]
18. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
19. Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology.
Apelt J; Bigl M; Wunderlich P; Schliebs R
Int J Dev Neurosci; 2004 Nov; 22(7):475-84. PubMed ID: 15465277
[TBL] [Abstract][Full Text] [Related]
20. Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP.
Faraco G; Park L; Zhou P; Luo W; Paul SM; Anrather J; Iadecola C
J Cereb Blood Flow Metab; 2016 Jan; 36(1):241-52. PubMed ID: 25920959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
